XTX Topco’s OptimizeRx OPRX Stock Holding History

XTX Topco’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Buy	46,497 +28,074	+152%	+$161K	﹤0.01%	3028
2026 Q1	$116K	Buy	+18,423	New	+$171K	﹤0.01%	3061
2025 Q3	–	Sell	-25,493	Closed	-$344K	–	3073
2025 Q2	$344K	Buy	+25,493	New	+$279K	0.01%	1336
2025 Q1	–	Sell	-36,674	Closed	-$178K	–	2908
2024 Q4	$178K	Buy	+36,674	New	+$205K	0.01%	1595
2022 Q1	–	Sell	-4,562	Closed	-$283K	–	885
2021 Q4	$283K	Buy	+4,562	New	+$346K	0.16%	228

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

XTX Topco's OPRX Position: Q2 2026 in Review

XTX Topco increased its OptimizeRx (OPRX) stake by 152% in Q2 2026, buying an estimated $161K and bringing the position to 46,497 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3028.

XTX Topco first reported a position in OPRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $344K in Q2 2025. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

XTX Topco held 46,497 shares of OptimizeRx worth $266K as of Q2 2026.
XTX Topco bought 28,074 OptimizeRx shares in Q2 2026, an estimated $161K.
OptimizeRx made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3028 holding.
XTX Topco first reported a position in OptimizeRx in Q4 2021 and has held it in 5 quarters since.
XTX Topco's OptimizeRx position peaked at $344K in Q2 2025.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.